"Medical Psych Care, PLLC is a team of Psychiatrists and Social Workers located in Westchester New York, where it maintains a private practice. Medical Psych care was established in 2004 by a group of physicians. The Psychiatrists at Medical Psych Care are affiliated with NS-LIJ Phelps Hospital, NY Presbyterian, Hudson Valley Hospital, and Montefiore Medical Center. The Medical Psych Care team has over twenty-five years of experiences in clinical care and research of geriatric individuals with Alzheimer’s, Dementia, and other age related illnesses. The Medical Psych Care Team is also recognized for treating individuals with depression, anxiety, bipolar disorder, attention disorders, addiction, and eating disorders."

During the past decade, Advanced Bio-Behavioral Sciences conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Advanced Bio-Behavioral Sciences" #1 collaborator was "Pfizer" with 3 trials as a collaborator and "Otsuka America Pharmaceutical" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Advanced Bio-Behavioral Sciences" are "Alzheimer's Disease" (3 trials), "Schizoaffective Disorder" (1 trials), "Schizophrenia" (1 trials) and "Schizophrenia and Predominant Negative Symptoms" (1 trials). Many other conditions were trialed in "Advanced Bio-Behavioral Sciences" in a lesser frequency.

Most popular intervention types in "Advanced Bio-Behavioral Sciences" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Bapineuzumab 0.5 mg/kg" (2 trials), "Bapineuzumab 1.0 m/kg" (2 trials), "Placebo Control" (2 trials), "Bapineuzumab" (1 trials) and "Placebo matching SPD489 (lisdexamfetamine dimesylate)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Advanced Bio-Behavioral Sciences" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Advanced Bio-Behavioral Sciences". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Advanced Bio-Behavioral Sciences, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Advanced Bio-Behavioral Sciences, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".